Bill Text: IL SB2697 | 2023-2024 | 103rd General Assembly | Introduced
NOTE: There are more recent revisions of this legislation. Read Latest Draft
Bill Title: Reinserts the provisions of the bill, as amended by Senate Amendment No. 1, with the following changes. Removes language concerning coverage for any cancer risk management strategy, as recommended by a health care professional. Requires, for individuals with a genetic test that is positive for an inherited mutation associated with an increased risk of cancer, coverage to include any evidence-based screenings, as recommended by a health care professional in accordance with current evidence-based clinical practice guidelines, to the extent that the management recommendation is not already covered by the policy, except that the coverage for the evidence-based screenings may be subject to a deductible, coinsurance, or other cost-sharing limitation. Defines "evidence-based screenings". Makes other changes. Amends the Illinois Public Aid Code. Subject to federal approval, requires the medical assistance program to provide coverage for clinical genetic testing for an inherited gene mutation for individuals with a personal or family history of cancer, as recommended by a health care professional in accordance with current evidence-based clinical practice guidelines. Requires, for individuals with a genetic test that is positive for an inherited mutation associated with an increased risk of cancer, coverage to include any evidence-based screenings, as recommended by a health care professional in accordance with current evidence-based clinical practice guidelines, to the extent that the management recommendation is not already covered by the medical assistance program. Changes to the Illinois Public Aid Code are effective January 1, 2025.
Spectrum: Moderate Partisan Bill (Democrat 42-6)
Status: (Enrolled) 2024-05-22 - Added Alternate Chief Co-Sponsor Rep. Marcus C. Evans, Jr. [SB2697 Detail]
Download: Illinois-2023-SB2697-Introduced.html
Bill Title: Reinserts the provisions of the bill, as amended by Senate Amendment No. 1, with the following changes. Removes language concerning coverage for any cancer risk management strategy, as recommended by a health care professional. Requires, for individuals with a genetic test that is positive for an inherited mutation associated with an increased risk of cancer, coverage to include any evidence-based screenings, as recommended by a health care professional in accordance with current evidence-based clinical practice guidelines, to the extent that the management recommendation is not already covered by the policy, except that the coverage for the evidence-based screenings may be subject to a deductible, coinsurance, or other cost-sharing limitation. Defines "evidence-based screenings". Makes other changes. Amends the Illinois Public Aid Code. Subject to federal approval, requires the medical assistance program to provide coverage for clinical genetic testing for an inherited gene mutation for individuals with a personal or family history of cancer, as recommended by a health care professional in accordance with current evidence-based clinical practice guidelines. Requires, for individuals with a genetic test that is positive for an inherited mutation associated with an increased risk of cancer, coverage to include any evidence-based screenings, as recommended by a health care professional in accordance with current evidence-based clinical practice guidelines, to the extent that the management recommendation is not already covered by the medical assistance program. Changes to the Illinois Public Aid Code are effective January 1, 2025.
Spectrum: Moderate Partisan Bill (Democrat 42-6)
Status: (Enrolled) 2024-05-22 - Added Alternate Chief Co-Sponsor Rep. Marcus C. Evans, Jr. [SB2697 Detail]
Download: Illinois-2023-SB2697-Introduced.html
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
1 | AN ACT concerning regulation.
| |||||||||||||||||||
2 | Be it enacted by the People of the State of Illinois, | |||||||||||||||||||
3 | represented in the General Assembly:
| |||||||||||||||||||
4 | Section 5. The Illinois Insurance Code is amended by | |||||||||||||||||||
5 | adding Section 356u.10 as follows:
| |||||||||||||||||||
6 | (215 ILCS 5/356u.10 new) | |||||||||||||||||||
7 | Sec. 356u.10. Genetic testing and evidence-based cancer | |||||||||||||||||||
8 | imaging. | |||||||||||||||||||
9 | (a) For the purposes of this Section: | |||||||||||||||||||
10 | "Cost-sharing requirement" means a deductible, | |||||||||||||||||||
11 | coinsurance, copayment, or any similar out-of-pocket expense. | |||||||||||||||||||
12 | "Evidence-based cancer imaging" means evidence-based | |||||||||||||||||||
13 | cancer imaging modalities in accordance with the most recent | |||||||||||||||||||
14 | version of the National Comprehensive Cancer Network clinical | |||||||||||||||||||
15 | practice guidelines. | |||||||||||||||||||
16 | "Genetic testing for an inherited mutation" means germline | |||||||||||||||||||
17 | multi-gene testing for an inherited mutation associated with | |||||||||||||||||||
18 | an increased risk of cancer in accordance with evidence-based, | |||||||||||||||||||
19 | clinical practice guidelines. | |||||||||||||||||||
20 | (b) A group policy of accident and health insurance that | |||||||||||||||||||
21 | provides coverage for hospital or medical treatment or | |||||||||||||||||||
22 | services for illness on an expense-incurred basis and that is | |||||||||||||||||||
23 | amended, delivered, issued, or renewed after January 1, 2025 |
| |||||||
| |||||||